# Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

> **NCT07474467** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **CellinCells** · enrollment: 31 (estimated)

## Conditions studied

- Atrophic Scar

## Interventions

- **BIOLOGICAL:** TRTP-101
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07474467
- **Lead sponsor:** CellinCells
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-02-01
- **Final completion:** 2029-08-01
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07474467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07474467, "Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07474467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*